Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus...
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 ... Primary Outcome Measures : *Percentage of Participants Achieving and Maintaining Confirmed HIV-1 RNA , 50 Copies/mL at Week 48 ... Participation in any other clinical trial (except for the etravirine or maraviroc expanded access program), without prior ... which defines a patient's virologic response status using the viral load along with study drug discontinuation status at the ...https://clinicaltrials.gov/show/NCT00707733?order=21
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer - Full Text...
Patients who have any severe and/or uncontrolled medical conditions or other conditions that could affect their participation ... A 3-Arm Randomized Phase II Trial Evaluating Single Agent and Combined Efficacy of Pasireotide and Everolimus in Adult Patients ... If the patient declines or is intolerant of radioiodine therapy or if with progressive disease that is, in the opinion of the ... The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study ...https://clinicaltrials.gov/ct2/show/NCT01270321?term=sirolimus+cancer&recr=Open&rank=17
Programme - European School of Oncology
Its primary aim is the development of international consensus guidelines for the management of ABC patients ... Efficacy and safety of eribulin in combination with trastuzimab in HER2-positive metastatic breast cancer patients: real life ... Share decision making for better patient participation in advanced breast cancer care. Marga Schrieks, NL. ... Effect of exercise on cardiovascular fitness and quality of life outcomes in advanced breast cancer patients (E. Oliveira, PT) ...http://www.abc-lisbon.org/en/programme/programme/1-508-1-
Guidelines for the Management of Inflammatory Bowel Disease... : Journal of Pediatric Gastroenterology and Nutrition
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998; 115: ... Patients already taking immunosuppressive drugs may have a false-negative Mantoux. Before starting treatment, the patient and ... Outcome of inpatient management of severe ulcerative colitis: a BSG IBD Clinical Trials Network survey. Gut 2002; 50:A16.. * ... Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis 2006; 12:1053-1057.. * ...http://journals.lww.com/jpgn/Fulltext/2010/02001/Guidelines_for_the_Management_of_Inflammatory.1.aspx
We cannot predict the outcome of such initiatives, but we will work to maintain patient access to our products and to oppose ... This means that after we have borne the expenses of discovering, developing and testing a medicine for safety and efficacy, ... If changes to Medicare shift patients to MCOs that cover 11 Table of Contents. pharmaceuticals, or if an outpatient drug ... under the supervision and with the participation of our principal executive officer and principal financial officer, of the ...https://www.sec.gov/Archives/edgar/data/78003/000095012303003360/y83976e10vk.htm
Course Content - #91150: Strategies for Appropriate Opioid Prescribing: The Florida Requirement - NetCE
... optimize patient attainment of therapeutic goals, and avoid the risk to patient outcome, public health, and viability of their ... A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids ... and problematic opioid use by patients. In doing so, healthcare professionals are more likely to achieve a balance between the ... Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, ...http://www.netce.com/coursecontent.php?courseid=1377
Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma - Full Text View - ClinicalTrials.gov
... phase II-study investigating safety and efficacy of the combination of auto-allo tandem stem cell transplantation in patients ... Primary Outcome Measures : *Event-free survival 4 years after auto-allo/ auto-auto Tandem-SCT. Any of the following will be ... Patient's written informed consent. *Women and men capable of reproduction must agree to use adequate contraceptive measures ( ... Participation in another trial at the time of registration. *Preceding autologous stem cell transplantation ...https://clinicaltrials.gov/show/NCT00777998
Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole - Full Text View -...
Secondary Outcome Measures: *Evaluate the safety of oral cotrimoxazole versus placebo in IPF. [ Time Frame: At 24 weeks ]. * ... Primary Outcome Measures: *Evaluate the efficacy of oral cotrimoxazole versus placebo in idiopathic pulmonary fibrosis (IPF ... may jeopardize the patient's health participating in the study or influence the results of the study or the patient's ability ... Participation in another trial with an investigational drug within 30 days or six half-lives (the larger of the two) above the ...https://clinicaltrials.gov/ct2/show/NCT01777737?recr=Open&cond=%22Pulmonary+Fibrosis%22&rank=18
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial - Full...
Patient is pregnant; OR. *Patient participation in a concurrent interventional trial whose protocol, in the judgment of the ... Exploring the safety and efficacy of targeted temperature management amongst infants with out-of-hospital cardiac arrest due to ... Efficacy outcome selection in the therapeutic hypothermia after pediatric cardiac arrest trials. Pediatr Crit Care Med. 2015 ... Patient is newborn with acute birth asphyxia; OR. _ Patient cared for in a neonatal intensive care unit (NICU) after arrest (ie ...https://clinicaltrials.gov/ct2/show/NCT00878644?term=Sudden+Cardiac+Arrest&recr=Open&fund=01&rank=4
Search of: Northwestern AND Smoking - List Results - ClinicalTrials.gov
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A ... This Study Will Focus on Recruitment Strategies and Attitudes Towards Research Among Patients Considering Participation in 2 ... The primary outcome is the proportion of people assigned to each recruitment strategy that consent to participate in the three ... Acute Exacerbation COPD Hospitalization Rates (Events/Patient Year). 885. All. 40 Years to 80 Years (Adult, Senior). ...https://clinicaltrials.gov/ct2/results?term=Northwestern+AND+Smoking&Search=Search
Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer - Full Text View -...
Primary Outcome Measures: *Tumour resectability at surgery [ Time Frame: 1 month ]. Secondary Outcome Measures: *Safety ... The objective of this study is to evaluate the safety and efficacy of Irinotecan Bead in the neoadjuvant treatment (i.e. the ... Patients with liver-dominant disease, defined as ≥80% of the tumour body burden confined to the liver. Unilobar disease, or ... Other significant medical or surgical condition, or any medication or treatment regimens, that would place the patient at undue ...https://clinicaltrials.gov/ct2/show/NCT00844233
August | 2017 | Contemplative Studies
... to understand the effect of stress on periodontal treatment outcome, (3) to evaluate the efficacy of yoga in the management of ... Improve Physician-Patient Interactions with Mindfulness. August 22, 2017. psyjdc Leave a comment ... Burnout it is a threat to the healthcare providers and their patients. In fact, it is a threat to the entire healthcare system ... The practice was found to be safe, as there were no significant adverse effects observed for participation in Tai Chi Softball ...http://contemplative-studies.org/wp/index.php/2017/08/
ExchangeCME :: Online Activities
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid ... Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own ... Physicians should claim only the credit commensurate with the extent of their participation in the activity. ... Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, ...http://www.exchangecme.com/raehealth
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke -...
Original Secondary Outcome Measures ICMJE (submitted: March 4, 2011). *Efficacy - Clinical Response [ Time Frame: Up to 24 ... requires or prolongs in-patient hospitalization; is a congenital anomaly/birth defect in the offspring of a patient; and ... prior to treatment with study therapy or planned participation in another therapeutic trial prior to the completion of this ... Original Primary Outcome Measures ICMJE (submitted: March 4, 2011). *Safety [ Time Frame: Up to 24 months ]. Number of ...https://clinicaltrials.gov/ct2/show/record/NCT01310114
The Carlat Psychiatry Blog: October 2008
... safety or efficacy.". All physicians taking the courses were asked by the researchers to estimate their use of these drugs over ... or payment for participation in online CME. A complete ban eases the burdens of compliance, biased decision making, and patient ... As patients, we can all rest easier knowing that there is no possibility of commercial influence in their decision making.. But ... "outcome switcheroo.". Today, let's look at one of the few empirical studies that has actually measured industry CME bias, and ...http://carlatpsychiatry.blogspot.com/2008_10_01_archive.html
Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo...
... reviewed unblinded safety data on an ongoing basis to ensure patient safety. This review did not identify any safety signal ... Safety and efficacy of up to 900 mg/day polysulfate sodium (Elmiron) in patients with interstitial cystitis . Urology . 2001 ; ... All patients provided written informed consent before study participation. The study is registered at clinicaltrials.gov, NCT ... Quality of life and functional outcome after infravesical desobstruction and... Quality of life and functional outcome after ...http://paperity.org/p/79142140/fulranumab-in-patients-with-interstitial-cystitis-bladder-pain-syndrome-observations-from
Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in MyoCardial Infarction - Full Text View - ClinicalTrials.gov
The study will determine the safety and feasibility of the IC infusion of investigational MPCs in this patient population. ... Primary Outcome Measures : *Frequency of the total major adverse cardiac and cerebrovascular events (MACCE) [ Time Frame: 24 ... Prior or current participation in any stem cell study or any other investigational trial in the past 30 days ... and efficacy data (if requested) periodically dependent on subject enrollment. ...https://clinicaltrials.gov/ct2/show/NCT01781390?term=heart+attack&lup_s=04%2F22%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
Interaction between crestor and garcinia cambogia - Herpeset - Natural Herpes Relief - Feb 21, 2018
Find patient medical information for Garcinia Cambogia (GARCINIA) on WebMD including its uses, effectiveness, side effects and ... Through participation in strategic partnerships, Jhpiego has extended its ability to make an impact on malaria globally. ... Each time a MedsFacts visitor researches a drug safety profile, they are given the option to post questions or concerns to ... eHealthMe.com enables people to find out what patients like me (same gender, age) reported their drugs and conditions on FDA ...http://herpeset.herbalyzer.com/interaction-between-crestor-and-garcinia-cambogia.html
A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems | Implementation...
... delay or cancel patients' surgeries), to indifference (little or no change in patient outcomes), to positive (save money, avoid ... The Influences on Patient Safety Behaviours Questionnaire IPSBQ , a 34-item tool based on the 12-domain version of the TDF ... Participation in physical play and leisure: developing a theory- and evidence-based intervention for children with motor ... Self-efficacy. Control-of behaviour and material and. Social environment. Perceived competence ...https://implementationscience.biomedcentral.com/articles/10.1186/s13012-017-0605-9
activities of daily living
... global outcome, and quality of life, and in prespecified patient subgroups, including patients with .. ... examined the efficacy and safety of the traditional Chinese herbal medicine Yi-Gan San (YGS, Yokukan-San in Japanese) in the ... Activity, participation, and quality of life 6 months poststroke. Nancy E Mayo. Division of Clinical Epidemiology, Royal ... The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. Nizar N Mahomed. ...http://www.labome.org/topics/sociology/human/activities-of-daily-living-16929.html
Does Clinical Trial Participation Improve Outcomes in Ovarian Cancer Patients? Khoja L, Horsley L, Heesters A, Machin JD, ... efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.. I ... Improving patient care and outcomes are everything. I am proud to be part of a diverse, talented group of people all working ... Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma. Khoja L, Atenafu EG, Ye Q ...https://www.astrazeneca.com/our-company/our-people/leila-khoja.html
HCV Research and News: March 2015
... patient-reported outcomes offer the opportunity to have the patient's voice more forcefully heard in health policy decision ... The ledipasvir/sofosbuvir single tablet regimen is an investigational product in Japan and its safety and efficacy have not yet ... Counsel patients about the risk of serious symptomatic bradycardia. • Cardiac monitoring in an in-patient setting for the first ... Some recent examples include: the recent single-sourcing of seven generic drugs; participation in the pan-Canadian price ...http://hepatitiscresearchandnewsupdates.blogspot.com/2015/03/
Non Invasive Multicenter Italian Study for Coronary Artery Disease - Full Text View - ClinicalTrials.gov
Secondary Outcome Measures : *the efficacy in terms of performance of the MDCT in each single coronary segment and. *the safety ... Patients must be willing and able to continue study participation following the reference test to ensure completion of all ... Data published for over 200 subjects from 4 studies demonstrated that patient compliance at breath-hold, heart rate and rhythm ... Primary Outcome Measures : *to determine if 16-64 slice multidetector CT (MDCT) can replace the invasive procedure in patients ...https://clinicaltrials.gov/show/NCT00539604
Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy - Full Text View - ClinicalTrials.gov
Other serious underlying medical conditions prohibiting the patient's participation in the trial according to the judgement of ... The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study ... Primary Outcome Measures: *Number of Participants with acute adverse effects as a Measure of toxicity [ Time Frame: 6 weeks ... Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital ...https://clinicaltrials.gov/ct2/show/NCT01192087?cond=%22Adenoid+cystic+carcinoma%22&rank=14
Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast
Although approximately 50% of new diagnosis breast cancers are in patients above the age of 65, elderly people remain ... Outcome Time Frame:. 4 months after Last Patient Out. Safety Issue:. Yes ... Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open ... Participation in. another clinical trial with any investigational not marketed drug.. 11. Concurrent treatment with virostatic ...http://www.knowcancer.com/cancer-trials/NCT01204437/